[go: up one dir, main page]

AU2001242184A1 - Methods for effecting neuroprotection using a potassium channel modulator - Google Patents

Methods for effecting neuroprotection using a potassium channel modulator

Info

Publication number
AU2001242184A1
AU2001242184A1 AU2001242184A AU4218401A AU2001242184A1 AU 2001242184 A1 AU2001242184 A1 AU 2001242184A1 AU 2001242184 A AU2001242184 A AU 2001242184A AU 4218401 A AU4218401 A AU 4218401A AU 2001242184 A1 AU2001242184 A1 AU 2001242184A1
Authority
AU
Australia
Prior art keywords
methods
potassium channel
channel modulator
effecting neuroprotection
neuroprotection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242184A
Inventor
Jaideep S. Bains
Alastair V. Ferguson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University at Kingston
Original Assignee
Queens University at Kingston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University at Kingston filed Critical Queens University at Kingston
Publication of AU2001242184A1 publication Critical patent/AU2001242184A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001242184A 2000-03-28 2001-03-27 Methods for effecting neuroprotection using a potassium channel modulator Abandoned AU2001242184A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19258500P 2000-03-28 2000-03-28
US60/192,585 2000-03-28
PCT/CA2001/000391 WO2001072335A2 (en) 2000-03-28 2001-03-27 Methods for effecting neuroprotection using a potassium channel modulator

Publications (1)

Publication Number Publication Date
AU2001242184A1 true AU2001242184A1 (en) 2001-10-08

Family

ID=22710287

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242184A Abandoned AU2001242184A1 (en) 2000-03-28 2001-03-27 Methods for effecting neuroprotection using a potassium channel modulator

Country Status (4)

Country Link
US (1) US20020022587A1 (en)
AU (1) AU2001242184A1 (en)
CA (1) CA2403555A1 (en)
WO (1) WO2001072335A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2290731A1 (en) * 1999-11-26 2001-05-26 D. Jed Harrison Apparatus and method for trapping bead based reagents within microfluidic analysis system
US6432290B1 (en) 1999-11-26 2002-08-13 The Governors Of The University Of Alberta Apparatus and method for trapping bead based reagents within microfluidic analysis systems
US20030108664A1 (en) * 2001-10-05 2003-06-12 Kodas Toivo T. Methods and compositions for the formation of recessed electrical features on a substrate
WO2003043615A2 (en) * 2001-11-23 2003-05-30 Solvay Pharmaceuticals Gmbh Hypertonia treatment during the acute phase of a cerebrovascular accident
US20030217923A1 (en) * 2002-05-24 2003-11-27 Harrison D. Jed Apparatus and method for trapping bead based reagents within microfluidic analysis systems
US7445926B2 (en) 2002-12-30 2008-11-04 The Regents Of The University Of California Fluid control structures in microfluidic devices
US7799553B2 (en) 2004-06-01 2010-09-21 The Regents Of The University Of California Microfabricated integrated DNA analysis system
CA2568640C (en) 2004-06-04 2011-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
US7745207B2 (en) 2006-02-03 2010-06-29 IntegenX, Inc. Microfluidic devices
CN102759466A (en) * 2004-09-15 2012-10-31 英特基因有限公司 Microfluidic devices
US7749365B2 (en) * 2006-02-01 2010-07-06 IntegenX, Inc. Optimized sample injection structures in microfluidic separations
US7766033B2 (en) * 2006-03-22 2010-08-03 The Regents Of The University Of California Multiplexed latching valves for microfluidic devices and processors
WO2008052138A2 (en) * 2006-10-25 2008-05-02 The Regents Of The University Of California Inline-injection microdevice and microfabricated integrated dna analysis system using same
KR20100028526A (en) 2007-02-05 2010-03-12 마이크로칩 바이오테크놀로지스, 인크. Microfluidic and nanofluidic devices, systems, and applications
US8454906B2 (en) * 2007-07-24 2013-06-04 The Regents Of The University Of California Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions
WO2009108260A2 (en) * 2008-01-22 2009-09-03 Microchip Biotechnologies, Inc. Universal sample preparation system and use in an integrated analysis system
EP2384429A1 (en) 2008-12-31 2011-11-09 Integenx Inc. Instrument with microfluidic chip
WO2010141326A1 (en) 2009-06-02 2010-12-09 Integenx Inc. Fluidic devices with diaphragm valves
WO2010141921A1 (en) 2009-06-05 2010-12-09 Integenx Inc. Universal sample preparation system and use in an integrated analysis system
US8584703B2 (en) 2009-12-01 2013-11-19 Integenx Inc. Device with diaphragm valve
US8512538B2 (en) 2010-05-28 2013-08-20 Integenx Inc. Capillary electrophoresis device
EP2606242A4 (en) 2010-08-20 2016-07-20 Integenx Inc MICROFLUIDIC DEVICES HAVING MECHANICALLY SEALED DIAPHRAGM VALVES
WO2012024658A2 (en) 2010-08-20 2012-02-23 IntegenX, Inc. Integrated analysis system
TWI592156B (en) * 2011-10-04 2017-07-21 艾可達醫療公司 Method for treating sensory motion damage associated with stroke using aminopyridine
US10865440B2 (en) 2011-10-21 2020-12-15 IntegenX, Inc. Sample preparation, processing and analysis systems
US20150136604A1 (en) 2011-10-21 2015-05-21 Integenx Inc. Sample preparation, processing and analysis systems
US10191071B2 (en) 2013-11-18 2019-01-29 IntegenX, Inc. Cartridges and instruments for sample analysis
GB2544198B (en) 2014-05-21 2021-01-13 Integenx Inc Fluidic cartridge with valve mechanism
CN113092563B (en) 2014-10-22 2024-06-07 尹特根埃克斯有限公司 Systems and methods for sample preparation, processing, and analysis

Also Published As

Publication number Publication date
US20020022587A1 (en) 2002-02-21
WO2001072335A3 (en) 2002-08-01
CA2403555A1 (en) 2001-10-04
WO2001072335A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2001242184A1 (en) Methods for effecting neuroprotection using a potassium channel modulator
AU2001253535A1 (en) Channel dancer
AU5557700A (en) New uses for potassium channel openers
AU2001284824A1 (en) Removable grip for a bucket
AU2002217353A1 (en) Gabaa modulating neurosteroids
AU4247500A (en) Method for traversing a flowchart
AU2001276031A1 (en) Branded channel
AU2001240525A1 (en) Method for covering a microfluidic assembly
AU2001247361A1 (en) Curable polythiol-cyclopolyene sealant compounds
AU2664301A (en) A seal
AU2002220625A1 (en) Method for producing a strip-shaped object
AU2001286965A1 (en) Sodium channel modulators
AU2003251968A1 (en) A method for the modulation of angiogenesis
AU2001273694A1 (en) Method for changing color
AU2001241421A1 (en) Bandwidth control technique for a laser
AU2002249809A1 (en) Potassium channel inhibitors
AUPQ945800A0 (en) A seal
AU2001281735A1 (en) Method for producing maltose syrup by using a hexosyltransferase
AU2001294695A1 (en) Method for optical modulation at periodic optical structure band edges
AU1908501A (en) A digital communication receiver containing a channel tracker and a method for the operation thereof
AU2001283351A1 (en) Method for setting a timer based on previous channel request statistics
AU2001251061A1 (en) Method for testing a communication channel
AU2002230566A1 (en) Seal for process tube
AU2000256183A1 (en) Chimeric hsf transcription factors
AU2001221413A1 (en) A channel estimating method